DataLibraryResearch is tracking the market dynamics of the crisis in the Pharma & Healthcare industry amid lock-down changes in the supply chain.

Get detailed analysis of the COVID-19 impact on the BCG Vaccine Market

Global BCG Vaccine Market Opportunities and Forecast 2020-2027

  • DLR2364
  • 16 September, 2021
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global BCG Vaccine Market, By Drug Type (Immune BCG, Therapy BCG), By Usage (Tuberculosis, Bladder Cancer), By End User (Pediatrics, Adults), and opportunities and forecast 2020-2027

BCG Vaccine Market Overview

Bacillus Calmette–Guerin (BCG) vaccine is usually given to newborn babies. Vaccination can be done from 6 months old to five years of age. According to World Health Organization, the annual risk of TB infection in children in high-burden countries is estimated to be 0.5-2%. Hence, BCG vaccines played an important role to protect newborns from tuberculosis and other similar diseases. This crucial factor is highly contributed to the growth of the global BCG vaccines market in the last few years.

Furthermore, increasing advancements in the vaccination camps. Also, solid campaigns in online and offline mode providing information to common people about proper vaccination in the current time. This important factor is expected to fuel the growth of the market. Also, the growing incidence of tuberculosis across the world and the rise in research activities for the development of the BCG vaccine are enhancing the market growth.  

On the other hand, side effects and a global shortage of BCG vaccines may hamper the growth of the market. Besides, favorable government initiatives and a good focus on the vaccination programs globally are expected to open new opportunities for leading vendors of BCG vaccines in the forthcoming years.

BCG Vaccine Market Segment Overview

The immune BCG segment holds the highest share in the market. This is on account of the major role of BCG in effectively helping TB prevention and as of now, there is no substitute vaccine for immune BCG. In addition, several new vendors are focusing on developing new vaccinations for bladder cancer is anticipated to boost the market growth in the coming years.

BCG Vaccine Market Regional Overview

The market of the Asia Pacific is expected to grow at the fastest rate over the forecasted period. This is due to the high demand for BCG vaccines for the prevention of tuberculosis in the region. For instance, The Government of India has announced its plan to eliminate TB by 2025 during the Union Budget 2017–2018. Additionally, the market in Latin America and the Middle East, and Africa is expected to show noteworthy growth due to increasing awareness about the BCG vaccines.  

BCG Vaccine Market Competitor overview

·       In April 2020, the Serum Institute of India launched human trials to test the new BCG vaccine that can boost immunity in the fight against Covid-19.

BCG Vaccine Market, Key Players

·     Intervax Ltd
·     Greensignal Bio Pharma Limited
·     AJ Vaccines
·     China National Pharmaceutical Group Corporation
·     Japan BCG Laboratory
·     Greensignal Bio Pharma Limited
·     Serum Institute of India Pvt. Ltd.
·     Merck & Company Inc
·     Sanofi S.A.
·     Statens Serum Institute
·     Gsbpl C
·     Shanghai Institute of Biological Products
·     Japan BCG Laboratory

BCG Vaccine Market Segmentation

BCG Vaccine Market, By Drug Type

·     Immune BCG
·     Therapy BCG

BCG Vaccine Market, By Usage

·     Tuberculosis
·     Bladder Cancer

BCG Vaccine Market, By End User

·     Pediatrics
·     Adults

BCG Vaccine market, By Region
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa


1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

    3. Market Dynamics

    • 3.1. Market Drivers
    • 3.2. Market Restraints
    • 3.3. Market Opportunities

    4. Key Insights

    • 4.1. Key Emerging Trends – For Major Countries
    • 4.2. Latest Technological Advancement
    • 4.3. Regulatory Landscape
    • 4.4. Industry SWOT Analysis
    • 4.5. Porters Five Forces Analysis

    5. Global BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 5.1. Key Findings / Summary
    • 5.2. Market Analysis, Insights and Forecast – By Drug Type
      • 5.2.1. Immune BCG
      • 5.2.2. Therapy BCG
    • 5.3. Market Analysis, Insights and Forecast – By Usage
      • 5.3.1. Tuberculosis
      • 5.3.2. Bladder Cancer
    • 5.4. Market Analysis, Insights and Forecast – By End User
      • 5.4.1. Pediatrics
      • 5.4.2. Adults
    • 5.5. Market Analysis, Insights and Forecast – By Region
      • 5.5.1. North America
      • 5.5.2. Latin America
      • 5.5.3. Europe
      • 5.5.4. Asia Pacific
      • 5.5.5. Middle East and Africa

    6. North America BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 6.1. Key Findings / Summary
    • 6.2. Market Analysis, Insights and Forecast – By Drug Type
      • 6.2.1. Immune BCG
      • 6.2.2. Therapy BCG
    • 6.3. Market Analysis, Insights and Forecast – By Usage
      • 6.3.1. Tuberculosis
      • 6.3.2. Bladder Cancer
    • 6.4. Market Analysis, Insights and Forecast – By End User
      • 6.4.1. Pediatrics
      • 6.4.2. Adults
    • 6.5. Market Analysis, Insights and Forecast – By Country
      • 6.5.1. U.S.
      • 6.5.2. Canada

    7. Latin America BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 7.1. Key Findings / Summary
    • 7.2. Market Analysis, Insights and Forecast – By Drug Type
      • 7.2.1. Immune BCG
      • 7.2.2. Therapy BCG
    • 7.3. Market Analysis, Insights and Forecast – By Usage
      • 7.3.1. Tuberculosis
      • 7.3.2. Bladder Cancer
    • 7.4. Market Analysis, Insights and Forecast – By End User
      • 7.4.1. Pediatrics
      • 7.4.2. Adults
    • 7.5. Insights and Forecast – By Country
      • 7.5.1. Brazil
      • 7.5.2. Mexico
      • 7.5.3. Rest of Latin America

    8. Europe BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 8.1. Key Findings / Summary
    • 8.2. Market Analysis, Insights and Forecast – By Drug Type
      • 8.2.1. Immune BCG
      • 8.2.2. Therapy BCG
    • 8.3. Market Analysis, Insights and Forecast – By Usage
      • 8.3.1. Tuberculosis
      • 8.3.2. Bladder Cancer
    • 8.4. Market Analysis, Insights and Forecast – By End User
      • 8.4.1. Pediatrics
      • 8.4.2. Adults
    • 8.5. Market Analysis, Insights and Forecast – By Country
      • 8.5.1. UK
      • 8.5.2. Germany
      • 8.5.3. France
      • 8.5.4. Italy
      • 8.5.5. Spain
      • 8.5.6. Russia
      • 8.5.7. Rest of Europe

    9. Asia Pacific BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 9.1. Key Findings / Summary
    • 9.2. Market Analysis, Insights and Forecast – By Drug Type
      • 9.2.1. Immune BCG
      • 9.2.2. Therapy BCG
    • 9.3. Market Analysis, Insights and Forecast – By Usage
      • 9.3.1. Tuberculosis
      • 9.3.2. Bladder Cancer
    • 9.4. Market Analysis, Insights and Forecast – By End User
      • 9.4.1. Pediatrics
      • 9.4.2. Adults
    • 9.5. Market Analysis, Insights and Forecast – By Country
      • 9.5.1. China
      • 9.5.2. India
      • 9.5.3. Japan
      • 9.5.4. Australia
      • 9.5.5. South East Asia
      • 9.5.6. Rest of Asia Pacific

    10. Middle East & Africa BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 10.1. Key Findings / Summary
    • 10.2. Market Analysis, Insights and Forecast – By Drug Type
      • 10.2.1. Immune BCG
      • 10.2.2. Therapy BCG
    • 10.3. Market Analysis, Insights and Forecast – By Usage
      • 10.3.1. Tuberculosis
      • 10.3.2. Bladder Cancer
    • 10.4. Market Analysis, Insights and Forecast – By End User
      • 10.4.1. Pediatrics
      • 10.4.2. Adults
    • 10.5. Market Analysis, Insights and Forecast – By Country
      • 10.5.1. GCC
      • 10.5.2. South Africa
      • 10.5.3. Rest of Middle East & Africa

    11. Competitive Analysis

    • 11.1. Company Market Share Analysis, 2018
    • 11.2. Key Industry Developments
    • 11.3. Company Profile
    • 11.4. Intervax Ltd
      • 11.4.1. Business Overview
      • 11.4.2. Segment 1 & Service Offering
      • 11.4.3. Overall Revenue
      • 11.4.4. Geographic Presence
      • 11.4.5. Recent Development
    *Similar details will be provided for the following companies
    • 11.5. Greensignal Bio Pharma Limited
    • 11.6. AJ Vaccines
    • 11.7. China National Pharmaceutical Group Corporation
    • 11.8. Japan BCG Laboratory
    • 11.9. Greensignal Bio Pharma Limited
    • 11.10. Serum Institute of India Pvt. Ltd.
    • 11.11. Merck & Company Inc
    • 11.12. Sanofi S.A.
    • 11.13. Statens Serum Institute
    • 11.14. Gsbpl C
    • 11.15. Shanghai Institute of Biological Products
    List of Figures

    Figure 1: Global BCG Vaccine Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
    Figure 2: Global BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 3: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 4: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 5: Global BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 6: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 7: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 8: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 9: Global BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
    Figure 10: Global BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 11: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 12: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 13: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 14: Global BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
    Figure 15: Global BCG Vaccine Market Value (USD Billion), by Region, 2019 & 2027
    Figure 16: North America BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 17: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 18: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 19: North America BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 20: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 21: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 22: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 23: North America BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
    Figure 24: North America BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 25: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 26: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 27: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 28: North America BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
    Figure 29: North America BCG Vaccine Market Forecast (USD Billion), by U.S., 2016-2027
    Figure 30: North America BCG Vaccine Market Forecast (USD Billion), by Canada, 2016-2027
    Figure 31: Latin America BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 32: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 33: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 34: Latin America BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 35: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 36: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 37: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 38: Latin America BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
    Figure 39: Latin America BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 40: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 41: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 42: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 43: Latin America BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
    Figure 44: Latin America BCG Vaccine Market Forecast (USD Billion), by Brazil, 2016-2027
    Figure 45: Latin America BCG Vaccine Market Forecast (USD Billion), by Mexico, 2016-2027
    Figure 46: Latin America BCG Vaccine Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
    Figure 47: Europe BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 48: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 49: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 50: Europe BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 51: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 52: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 53: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 54: Europe BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
    Figure 55: Europe BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 56: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 57: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 58: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 59: Europe BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
    Figure 60: Europe BCG Vaccine Market Forecast (USD Billion), by U.K., 2016-2027
    Figure 61: Europe BCG Vaccine Market Forecast (USD Billion), by Germany, 2016-2027
    Figure 62: Europe BCG Vaccine Market Forecast (USD Billion), by France, 2016-2027
    Figure 63: Europe BCG Vaccine Market Forecast (USD Billion), by Italy, 2016-2027
    Figure 64: Europe BCG Vaccine Market Forecast (USD Billion), by Spain, 2016-2027
    Figure 65: Europe BCG Vaccine Market Forecast (USD Billion), by Russia, 2016-2027
    Figure 66: Europe BCG Vaccine Market Forecast (USD Billion), by Rest of Europe, 2016-2027
    Figure 67: Asia Pacific BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 68: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 69: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 70: Asia Pacific BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 71: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 72: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 73: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 74: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
    Figure 75: Asia Pacific BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 76: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 77: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 78: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 79: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
    Figure 80: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by China, 2016-2027
    Figure 81: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by India, 2016-2027
    Figure 82: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Japan, 2016-2027
    Figure 83: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Australia, 2016-2027
    Figure 84: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Southeast Asia, 2016-2027
    Figure 85: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
    Figure 86: Middle East & Africa BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 87: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 88: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 89: Middle East & Africa BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 90: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 91: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 92: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 93: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
    Figure 94: Middle East & Africa BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 95: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 96: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 97: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 98: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
    Figure 99: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by GCC, 2016-2027
    Figure 100: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by South Africa, 2016-2027
    Figure 101: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
    List of Tables
    Table 1: Global BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 2: Global BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 3: Global BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 4: Global BCG Vaccine Market Revenue (USD Billion) Forecast, by Region, 2016-2027
    Table 5: North America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 6: North America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 7: North America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 8: North America BCG Vaccine Market Revenue (USD Billion) Forecast, by Country, 2016-2027
    Table 9: Europe BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 10: Europe BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 11: Europe BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 12: Europe BCG Vaccine Market Revenue (USD Billion) Forecast, by Country, 2016-2027
    Table 13: Latin America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 14: Latin America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 15: Latin America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 16: Latin America BCG Vaccine Market Revenue (USD Billion) Forecast, by Country, 2016-2027
    Table 17: Asia Pacific BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 18: Asia Pacific BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 19: Asia Pacific BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 20: Asia Pacific BCG Vaccine Market Revenue (USD Billion) Forecast, by Country, 2016-2027
    Table 21: Middle East & Africa BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 22: Middle East & Africa BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 23: Middle East & Africa BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 24: Middle East & Africa BCG Vaccine Market Revenue (USD Billion) Forecast, by Country, 2016-2027

    Report You Might be Interested

    Choose License Type

    • USD
    • GBP
    • EURO
    • INR
    Credit card Logo

    Happy To Assist You

    Have a Question? email us at

    info@datalibraryresearch.com

    Or Call Us On

    US +1 360 851 1343

    IND +91 880 579 4934